These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1361275)

  • 1. The enigma of cyclosporin A treatment for psoriasis: systemic efficacy versus topical non-responsiveness. A review.
    Mrowietz U
    Acta Derm Venereol; 1992 Sep; 72(5):321-6. PubMed ID: 1361275
    [No Abstract]   [Full Text] [Related]  

  • 2. Intralesional cyclosporin in psoriasis.
    Powles AV; Baker BS; McFadden JP; Valdimarsson H; Fry L
    Acta Derm Venereol Suppl (Stockh); 1989; 146():148-9; discussion 149-50. PubMed ID: 2609857
    [No Abstract]   [Full Text] [Related]  

  • 3. Intralesional cyclosporin in psoriasis: effects on T lymphocyte and dendritic cell subpopulations.
    Baker BS; Powles AV; Savage CR; McFadden JP; Valdimarsson H; Fry L
    Br J Dermatol; 1989 Feb; 120(2):207-13. PubMed ID: 2784322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and local administration of cyclosporine in the treatment of psoriasis.
    Griffiths CE
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1242-6; discussion 1246-7. PubMed ID: 2277131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the T cell in psoriasis and the action of cyclosporin in this disease.
    Fry L
    Acta Derm Venereol Suppl (Stockh); 1989; 146():133-4; discussion 134-5. PubMed ID: 2609854
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of cyclosporin A in psoriasis: a summary of the United States' experience.
    Fradin MS; Ellis CN; Voorhees JJ
    Br J Dermatol; 1990 Jun; 122 Suppl 36():21-5. PubMed ID: 2196080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical cyclosporin A in psoriasis.
    Schulze HJ; Mahrle G; Steigleder GK
    Br J Dermatol; 1990 Jan; 122(1):113-4. PubMed ID: 2297498
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical clearing of psoriasis by 6-thioguanine correlates with cutaneous T-cell depletion via apoptosis: evidence for selective effects on activated T lymphocytes.
    Murphy FP; Coven TR; Burack LH; Gilleaudeau P; Cardinale I; Auerbach R; Krueger JG
    Arch Dermatol; 1999 Dec; 135(12):1495-502. PubMed ID: 10606055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: a clinical and pathologic study.
    Gottlieb SL; Heftler NS; Gilleaudeau P; Johnson R; Vallat VP; Wolfe J; Gottlieb AB; Krueger JG
    J Am Acad Dermatol; 1995 Oct; 33(4):637-45. PubMed ID: 7545705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional injection of cyclosporin in psoriasis.
    Powles AV; Baker BS; McFadden J; Rutman AJ; Griffiths CE; Fry L; Valdimarsson H
    Lancet; 1988 Mar; 1(8584):537. PubMed ID: 2893957
    [No Abstract]   [Full Text] [Related]  

  • 11. Acrodermatitis continua-type of pustular psoriasis responds to low-dose cyclosporine.
    Peter RU; Ruzicka T; Donhauser G; Braun-Falco O
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 1):515-6. PubMed ID: 2212157
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidermal ICAM-1 in psoriasis after long-term cyclosporin.
    Edwards B; Ballardie F; Andrew S; Freemont A; O'Driscoll J; Chalmers R
    Lancet; 1991 Jun; 337(8754):1420. PubMed ID: 1674801
    [No Abstract]   [Full Text] [Related]  

  • 13. Generalized pustular psoriasis (von Zumbusch) responding to cyclosporin A.
    Meinardi MM; Westerhof W; Bos JD
    Br J Dermatol; 1987 Feb; 116(2):269-70. PubMed ID: 3828221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cyclosporin on human epidermal keratinocytes in vitro.
    Dykes PJ; Brunt J; Marks R
    Br J Dermatol; 1990 Feb; 122(2):173-80. PubMed ID: 2317446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic, phenotypic, and functional analyses of T cells in patients with psoriasis undergoing systemic cyclosporin A treatment.
    Takashima A; Morita A
    J Invest Dermatol; 1991 Mar; 96(3):376-82. PubMed ID: 1672138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine A in psoriasis: an immunohistological study.
    Mozzanica N; Cattaneo A; Pigatto PD; Finzi AF
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):78-84. PubMed ID: 3260053
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of action and rationale for cyclosporin A in psoriasis.
    Borel JF
    Br J Dermatol; 1990 Jun; 122 Suppl 36():5-12. PubMed ID: 2369569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional cyclosporine in the treatment of psoriasis. A clinical, immunologic, and pharmacokinetic study.
    Ho VC; Griffiths CE; Ellis CN; Gupta AK; McCuaig CC; Nickoloff BJ; Cooper KD; Hamilton TA; Voorhees JJ
    J Am Acad Dermatol; 1990 Jan; 22(1):94-100. PubMed ID: 2298969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of cyclosporine A on T lymphocyte and dendritic cell subpopulations in psoriasis.
    Baker BS; Griffiths CE; Lambert S; Powles AV; Leonard JN; Valdimarsson H; Fry L
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):72-7. PubMed ID: 3260052
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporin in erythrodermic psoriasis.
    Reitamo S; Mustakallio KK
    Acta Derm Venereol Suppl (Stockh); 1989; 146():140-1. PubMed ID: 2532843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.